← Browse entries

Mtbp

M. musculus

MDM2 binding protein

What the model saw

Gene: Mtbp
Organism: Mus musculus
Known functions: MDM2 binding protein. mdm2-binding protein. protein binding.
View unredacted entry
MDM2 binding protein. mdm2-binding protein. protein binding.

Solver output

Predicted influence
Pro-longevity
Confidence
62%
Mechanism
Cellular senescence
Reasoning

MTBP (MDM2 Binding Protein) binds to MDM2, the primary E3 ubiquitin ligase responsible for targeting p53 for proteasomal degradation. By binding MDM2, MTBP can inhibit MDM2's ability to ubiquitinate and degrade p53, thereby stabilizing p53 activity. Enhanced p53 signaling promotes tumor suppression, DNA damage responses, and regulation of cellular senescence pathways. In the context of aging, robust p53-mediated responses help prevent genomic instability and oncogenic transformation, which are hallmarks of aging-associated tissue dysfunction. Additionally, MTBP has been shown to have roles in replication fork protection and DNA replication stress responses, further supporting genome integrity. Thus, MTBP's normal function of restraining MDM2 and supporting p53 activity is broadly pro-longevity through maintenance of cellular homeostasis and tumor suppression.

Key pathways
MDM2-p53 tumor suppressor axisDNA damage responsecellular senescence regulation
Longevity influence
Anti-longevity
Lifespan effect
Increase

GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.

Advisor judgment

Answer
Incorrect
Mechanism
Incorrect
Reasoning quality
2/5
Failure mode
Confident wrong
Notes

The model predicted pro_longevity but the ground truth is anti_longevity. The model's mechanistic reasoning about MTBP inhibiting MDM2 and thereby stabilizing p53 is plausible in isolation, but it leads to the wrong conclusion. In reality, MTBP (MDM2 Binding Protein) has been shown to promote cell proliferation and tumor growth rather than suppress them. MTBP actually acts as a pro-proliferative factor, and its overexpression or activity can promote cancer and reduce longevity. The model incorrectly assumed that binding MDM2 necessarily means inhibiting it in a tumor-suppressive way, when MTBP's actual biological role is more complex and its net effect on aging is anti-longevity. The model's confidence of 0.62 is moderate but still committed to the wrong answer with a plausible-sounding but ultimately incorrect mechanistic narrative.

Raw API responses

solver

{
  "reasoning": "MTBP (MDM2 Binding Protein) binds to MDM2, the primary E3 ubiquitin ligase responsible for targeting p53 for proteasomal degradation. By binding MDM2, MTBP can inhibit MDM2's ability to ubiquitinate and degrade p53, thereby stabilizing p53 activity. Enhanced p53 signaling promotes tumor suppression, DNA damage responses, and regulation of cellular senescence pathways. In the context of aging, robust p53-mediated responses help prevent genomic instability and oncogenic transformation, which are hallmarks of aging-associated tissue dysfunction. Additionally, MTBP has been shown to have roles in replication fork protection and DNA replication stress responses, further supporting genome integrity. Thus, MTBP's normal function of restraining MDM2 and supporting p53 activity is broadly pro-longevity through maintenance of cellular homeostasis and tumor suppression.",
  "confidence": 0.62,
  "key_pathways": [
    "MDM2-p53 tumor suppressor axis",
    "DNA damage response",
    "cellular senescence regulation"
  ],
  "mechanism_class": "cellular_senescence",
  "longevity_influence": "pro_longevity"
}

advisor

{
  "notes": "The model predicted pro_longevity but the ground truth is anti_longevity. The model's mechanistic reasoning about MTBP inhibiting MDM2 and thereby stabilizing p53 is plausible in isolation, but it leads to the wrong conclusion. In reality, MTBP (MDM2 Binding Protein) has been shown to promote cell proliferation and tumor growth rather than suppress them. MTBP actually acts as a pro-proliferative factor, and its overexpression or activity can promote cancer and reduce longevity. The model incorrectly assumed that binding MDM2 necessarily means inhibiting it in a tumor-suppressive way, when MTBP's actual biological role is more complex and its net effect on aging is anti-longevity. The model's confidence of 0.62 is moderate but still committed to the wrong answer with a plausible-sounding but ultimately incorrect mechanistic narrative.",
  "failure_mode": "confident_wrong",
  "answer_correct": false,
  "mechanism_correct": false,
  "reasoning_quality": 2,
  "ground_truth_questionable": false
}